Compare Illumina, Inc. (ILMN) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Stanley Black & Decker, Inc. — how do they compare? Illumina, Inc. trades at $190.08 (market cap $27.94B), while Stanley Black & Decker, Inc. trades at $88.8 (market cap $13.60B). The key difference: Illumina, Inc. is far larger — about 2.1× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays a 3.79% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | SWK | |
|---|---|---|
Market Cap | $27.94B | $13.60B |
Sector | Health | — |
52-Week High | $194.33 | $94.12 |
52-Week Low | $91.00 | $62.12 |
Enterprise Value | $29.33B | $19.77B |
Dividend Yield | — | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Stanley Black & Decker (SWK) trades at $87.52, down 2.94% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company has beaten earnings estimates for the last three quarters, with Q2 2026 results expected soon. Revenue has stabilized around $15.1B in 2025, while net income improved to $402M. The stock carries a P/E of 36.95 and a dividend yield supported by recent payouts.
SWK shows operational resilience with consistent cash flow and debt reduction, but faces headwinds in Tools & Outdoor demand. Analyst sentiment is mixed with a consensus hold rating; the stock offers value and momentum potential amid ongoing cost-saving initiatives and aerospace growth, though high debt and consumer weakness pose risks to near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
